Meriwether Wealth & Planning, LLC

Position in LLY — ELI LILLY & Co

CIK 2055554 MINDEN, LA

Position in LLY

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$509,757

+$111,497 QoQ

Shares Held

425

-1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.80%

of 13F equity value

Holder Rank

#3,741

of 4,605 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Meriwether Wealth & Planning, LLC holds $2,667,532 across 5 Drug Manufacturers - General names. LLY ranks #3 (19.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	6,134	$961,320
2	ABBV	AbbVie Inc.	2,438	$613,498
3	LLY	ELI LILLY & Co This page	425	$509,757
4	AMGN	Amgen Inc	1,026	$371,535
5	PFE	Pfizer Inc	8,780	$211,422

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$509,757	425	-1.8%	Shares	Sole	2026-07-08
2026-03-31	$398,260	433	+0.5%	Shares	Sole	2026-04-09
2025-12-31	$463,187	431	-2.0%	Shares	Sole	2026-01-14
2025-09-30	$335,720	440	-12.9%	Shares	Sole	2025-10-15
2025-06-30	$393,662	505	+0.6%	Shares	Sole	2025-07-11
2025-03-31	$414,606	502	+4.6%	Shares	Sole	2025-04-21
2024-12-31	$370,560	480	—	Shares	Sole	2025-02-07
No filing history on record for this holder in this stock.